PlatinaPlasmids Inc. is a Japanese bio-venture startup (founded 2023) originating from Professor Hodaka Fujii's lab at Hirosaki University Graduate School of Medicine. Provides proprietary technology for mass amplification of problematic plasmid DNA that is difficult to propagate in standard E. coli due to repetitive sequences. Serves pharma and academia for gene therapy and mRNA vaccine development. Not a drug manufacturer -- provides plasmid amplification and construction services as a research supplier.
Plasmid DNA amplification, difficult-to-propagate plasmid handling, proprietary E. coli strain technology for stable plasmid replication
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.